Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous ...

GlaxoSmithKline PLCGSK-0.10%decrease; red down pointing triangle on Monday said it would buy cancer-focused drug company Tesaro Inc. for about $4.16 billion, positioning the health-care giant in a ...

Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

April 25 (Reuters) - GlaxoSmithKline (GLAX.NS), opens new tab sued Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab in Delaware federal court on Thursday, accusing them of ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

GlaxoSmithKline PLC is a pharmaceutical giant that operates on a global scale. The company has already released research and medications that saved millions of lives. Explore the global leaders of ...

By Blake Brittain (Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in ...